Gemini Biosciences launches new proteomics and antibody services
We are delighted to introduce our new proteomics and antibody services designed for scientists and researchers developing biopharmaceuticals including bio-similar therapeutic antibodies and comparability studies. The services could also be useful for research scientists who wish to better characterise their reagents prior to use in their research projects.
The new proteomics services we have introduced include: C termini sequencing of proteins,
As regards new antibody services, we are now offering monoclonal antibody (mAB) impurity
which makes use of our excellent proteomics services.
Please visit our website for more information about our processes and the applications of these research services.